<DOC>
	<DOCNO>NCT00640523</DOCNO>
	<brief_summary>To evaluate effectiveness safety forodesine CLL patient</brief_summary>
	<brief_title>Phase II Study Forodesine Subjects With Chronic Lymphocytic Leukemia ( CLL )</brief_title>
	<detailed_description>To investigate efficacy ( complete response [ CR ] + partial response [ PR ] ) forodesine treat subject CLL fail least one prior treatment regimen treatment naïve either elderly , poor performance status otherwise predict tolerate cytotoxic chemotherapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>1 . Age 18 year old 2 . Diagnosis CLL establish peripheral blood and/or bone marrow examination use standard diagnostic criterion . 3 . Subjects Rai stage III IV , early stage require therapy determine 1996 National Cancer Institute Working Group ( NCIWG ) criterion 4 . Primary resistant ( CR PR ) progressive disease response least one prior treatment regimen OR treatment naïve subject meet least one follow criterion . 1. age &gt; 65 year 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status 2 , 3 , 4 3 . Inability tolerate standard cytotoxic chemotherapy opinion treat physician . 5 . ECOG performance status 0 , 1 , 2 ( subject primary resistance progressive disease response least one prior treatment regimen ) . 6 . Willing take adequate contraceptive measure ( i.e. , latex condom , cervical cap , diaphragm , abstinence , etc . ) entire duration study 3 month , except patient post menopausal prior hysterectomy . 7 . All investigational treatment discontinue least 3 week prior initiation study drug . 1 . Pregnant nursing . 2 . Unable unwilling sign consent . 3 . Severe , ongoing comorbid condition , would preclude safe delivery investigational therapy . 4 . Active serious infection control antibiotic . 5 . ECOG performance status &gt; 2 ( except treatment naïve subject ECOG performance status 0 , 1 5 exclude ) . 6 . Inadequate renal function : creatinine &gt; equal 2.0 unless related disease . 7 . Inadequate liver function : bilirubin &gt; equal 3.0 ; transaminase &gt; equal 3.0 time upper limit normal unless related disease . 8 . Known positive test human immunodeficiency virus ( HIV ) . 9 . Subjects know hepatitis B and/or hepatitis C active infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>